| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.002 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.002 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.085 | 0.003 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.004 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.081 | 0.004 |